(5)According to the opinions of 29 June 2017, MBO is classified as carcinogenic category 1B in accordance with Regulation (EC) No 1272/2008 of the European Parliament and of the Councilnote, and therefore meets the exclusion criterion set out in Article 5(1), point (a), of Regulation (EU) No 528/2012.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.